LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Fresenius Medical Care AG & Co KGaA

Uždarymo kaina

28.52 -0.35

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

28.46

Max

28.56

Pagrindiniai rodikliai

By Trading Economics

Pajamos

71M

190M

Pardavimai

-203M

4.9B

P/E

Sektoriaus vid.

24

51.198

Pelnas, tenkantis vienai akcijai

0.42

Dividendų pajamingumas

2.73

Pelno marža

3.884

Darbuotojai

112,035

EBITDA

460M

741M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+25.76% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.73%

2.40%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.9B

17B

Ankstesnė atidarymo kaina

28.87

Ankstesnė uždarymo kaina

28.52

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Fresenius Medical Care AG & Co KGaA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-30 12:58; UTC

Rinkos pokalbiai

Weaker Dollar to Weigh on European Luxury, Healthcare, Aerospace Sectors -- Market Talk

2025-05-06 07:06; UTC

Rinkos pokalbiai
Uždarbis

Fresenius Medical Care's Results Are Solid But U.S. Dialysis Treatment Growth Disappoints -- Market Talk

2025-05-06 06:42; UTC

Rinkos pokalbiai
Uždarbis

Fresenius Medical Care's Results Should Lead to Positive Market Reaction -- Market Talk

2025-03-21 08:19; UTC

Rinkos pokalbiai

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

2025-02-25 10:27; UTC

Rinkos pokalbiai
Uždarbis

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

2024-07-15 08:17; UTC

Rinkos pokalbiai

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Akcijų palyginimas

Kainos pokytis

Fresenius Medical Care AG & Co KGaA Prognozė

Kainos tikslas

By TipRanks

25.76% į viršų

12 mėnesių prognozė

Vidutinis 36.03 USD  25.76%

Aukščiausias 49.202 USD

Žemiausias 28.9 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fresenius Medical Care AG & Co KGaA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

2

Pirkti

1

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

25.57 / 28.18Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Fresenius Medical Care AG & Co KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.